Highnoon Laboratories Limited's latest marketcap:
As of 07/26/2025, Highnoon Laboratories Limited's market capitalization has reached $199.75 M. According to our data, Highnoon Laboratories Limited is the 20395th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 199.75 M |
| Revenue (ttm) | 90.07 M |
| Net Income (ttm) | 12.48 M |
| Shares Out | 52.98 M |
| EPS (ttm) | 0.24 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 04/18/2025 |
| Earnings Date | 08/26/2025 |
Highnoon Laboratories Limited's yearly market capitalization.
| Date | Market Cap(rs) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/26/2025 | rs56.58 B | $199.75 M | 17.63% | 20395 |
| 12/31/2024 | rs48.65 B | $172.22 M | 81.98% | 19896 |
| 12/29/2023 | rs26.73 B | $93.57 M | 18.17% | 23490 |
| 12/30/2022 | rs22.62 B | $98.87 M | -5.37% | 22355 |
| 12/31/2021 | rs23.91 B | $134.35 M | 15.14% | 21221 |
| 12/31/2020 | rs20.76 B | $128.52 M | 22.81% | 19169 |
| 12/31/2019 | rs16.91 B | $108.37 M | 69.99% | 17700 |
| 12/31/2018 | rs9.95 B | $71.21 M | -9.45% | 19068 |
| 12/29/2017 | rs10.98 B | $98.85 M | -24.63% | 18041 |
| 12/30/2016 | rs14.57 B | $138.88 M | 23.95% | 14390 |
Company Profile
About Highnoon Laboratories Limited
Highnoon Laboratories Limited, along with its subsidiaries, is a leading manufacturer, importer, exporter, and marketer of pharmaceutical and consumer healthcare products. The company operates both domestically and internationally, delivering high-quality healthcare solutions.
Product Portfolio
The company offers a diverse range of products across multiple therapeutic areas, including:
- Allergy
- Anti-infective
- Cardiology
- Gastroenterology
- Metabolic
- Musculoskeletal
- Obstetrics & Gynaecology
- Paediatrics
- Respiratory
- Urology
Additionally, Highnoon Laboratories provides a variety of generic pharmaceutical products under well-established brand names.
Global Presence
The company serves markets in:
- Pakistan
- Afghanistan
- United Arab Emirates
- France
- Kenya
- Iraq
- Cambodia
- Tanzania
- Other international regions
Company Background
Founded in 1984, Highnoon Laboratories Limited is headquartered in Lahore, Pakistan. Over the years, the company has established itself as a trusted name in the pharmaceutical industry.
Frequently Asked Questions
-
What is Highnoon Laboratories Limited's (PSX-HINOON) current market cap?As of 07/26/2025, Highnoon Laboratories Limited (including the parent company, if applicable) has an estimated market capitalization of $199.75 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Highnoon Laboratories Limited (PSX-HINOON) rank globally by market cap?Highnoon Laboratories Limited global market capitalization ranking is approximately 20395 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.